1.90 +0.02 (1.05%)
DDSS
Stock Details
Last Trade:1.90 Change:+0.02 (1.05%) Prev Close:1.88 Open: 1.90 Days Range:1.83 – 2.03 52 Week Range: 0.76 - 2.99 Volume:2956864 P/E: N/AEPS:0.00
View AllRecent Alerts 02/09/10
Recent Alert on 02/03/10 at 2:18pm
Canaccord Adams Raises Price Target On Labopharm (DDSS) After Oleptro Approval, Partnership Is Next
Canaccord Adams Raises Price Target On Labopharm (DDSS) After Oleptro Approval, Partnership Is Next
Canaccord Adams raised their price target on Labopharm Inc. (Nasdaq: DDSS) from C$2.80 to $C$3.15 after the company gained FDA approval for Oleptro, its once-daily version of the anti-depressant trazodone. This approval came more than a week ahead... Read More
Recent Alert on 02/03/10 at 10:19am
Morning Movers 2/3: HDIX, BGP, APKT, TDSC, CGX, NETL Higher; XIDE, VSR, PLNR, R, CNLG Lower
Morning Movers 2/3: HDIX, BGP, APKT, TDSC, CGX, NETL Higher; XIDE, VSR, PLNR, R, CNLG Lower
Recent Alert on 01/11/10 at 8:21am
BioCentury Publishes BioTech Picks for FY10 (HGSI, VRTX, AMGN, More...)
BioCentury Publishes BioTech Picks for FY10 (HGSI, VRTX, AMGN, More...)
Recent Alert on 01/08/10 at 12:33pm
Labopharm (DDSS) Settles Previously Announced $1M Draw Down with YA Global Master
Labopharm (DDSS) Settles Previously Announced $1M Draw Down with YA Global Master
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
View AllRecent Blog Posts
Blog Posts on 07/20/09 at 11:09am
FDA Calendar Updates: Spectrum, Labopharm, Human Genome Sciences, Orexigen, Trinity
FDA Calendar Updates: Spectrum, Labopharm, Human Genome Sciences, Orexigen, Trinity